Cancer Research
-
Younger Adults in India’s Capital Face Rising Cancer Burden
NEW DELHI, July 5 — For decades, cancer carried an image of being an illness that arrived late in life. That image…
-
Samuel Mathias’ chest pains turn out to be rare cancer diagnosis
MELBOURNE, July 5 — A young finance professional who dismissed a strange chest ache as a training strain was later diagnosed with…
-
James P. Allison: Nobel Laureate Who Unleashed Immunity on Cancer
HOUSTON, July 5 — The figure that matters: 2011. That is the year the FDA approved ipilimumab, the first immune checkpoint inhibitor,…
-
UK Trial to Test CY-101 in Rare Cancer Patients Through 2032
LONDON, July 5 — A new immunotherapy drug is entering clinical trials for patients with a rare and aggressive adrenal gland cancer…
-
Swiss Team to Test Light-Activated Cancer Kill Switch in Animals
The next step for the Swiss team is already clear: find out if the light switch works inside a living animal. The…
-
ETH Zürich Develops Light-Activated Molecule Targeting Dormant Cancer Cells
One number sits at the center of this new cancer research: the glucocorticoid receptor. It is a single protein. It is the…
-
Tel Aviv researchers uncover cancer growth mechanism
TEL AVIV, July 4 — Researchers at Tel Aviv University have documented a mechanism by which cancerous tumors hijack a routine immune-system…
-
CPLE Phase III Trial Shows Faster Recovery from Chemo Side Effects
MUMBAI, July 3 — A new Phase III randomised clinical trial from Tata Memorial Centre’s GI medical oncology department has validated the…
-
Global Cervical Cancer Treatment Market to Hit $14.43B by 2034
NEW YORK, July 3 — Behind every number in a market report is a person. A mother, a sister, a friend. That’s…
-
Targeted Therapies Dominate Renal Cancer Drug Pipeline Through 2026
NEW YORK, July 3 — A comprehensive report on the renal cancer pipeline for 2026 has identified over 80 pipeline drugs and…
-
Researchers Use Vitamin B12 to Deliver Glioblastoma Drug Past Blood-Brain Barrier
History is littered with promising cancer treatments that worked beautifully in mice and then fell apart in people. That sobering fact hangs…
-
Researchers Use Vitamin B12 to Bypass Blood-Brain Barrier in Glioblastoma Fight
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
Fatty liver disease may directly fuel aggressive bowel cancer spread
LONDON, July 3 — A fatty liver may be more than a metabolic warning sign. New research published in the journal Nature…
-
Vitamin B12 compound shows promise against deadly brain cancer
BOSTON — A modified form of vitamin B12, designed to deliver nitric oxide directly to tumors, has shown promise in early animal…
-
Modified B12 compound crosses blood-brain barrier, shows sustained anti-tumor activity
A modified vitamin B12 compound that sneaks past the brain’s defenses has cleared animal testing for glioblastoma. The next steps are concrete,…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
Father’s Hope Shattered as Rare Brain Cancer Returns
SOUTH SHIELDS, July 2 — A first-time father has been told he has up to 12 months to live after a routine…
-
Tumor Mutation, High-Fat Diet Spur Cachexia in Mice
CHICAGO, July 2 — A newly discovered pathway linking lung tumor genetics, diet, and the nervous system drives cancer-associated cachexia in mice,…
-
Experimental Drug Blocks 90% of Pancreatic Cancer Spread in Lab
TALLAHASSEE, July 2 — In a Florida lab, researchers have watched pancreatic cancer cells essentially stop in their tracks. The experimental compounds…
-
ASCO 2026 insights spotlight hurdles in refining oncology trial designs
TORONTO, July 2 — Oncology experts are set to gather for a free webinar hosted by Xtalks, focusing on how data from…
-
Florida A&M researchers test new drug class targeting previously untreatable pancreatic cancer
For decades, the KRAS gene was considered untouchable. A single mutation in this gene drives rapid cell division in pancreatic ductal adenocarcinoma,…
-
High-Fat Diet Worsens Wasting Syndrome in Mice with Lkb1 Mutation
CHICAGO — The numbers tell a grim story. In mice with lung tumors carrying a specific genetic flaw, a high-fat diet did…
-
Muscle cells found to release anti-cancer signals, study reveals
SINGAPORE — A new study from Duke-NUS Medical School suggests that aging muscle does not simply lose strength — it may also…
-
Melanoma’s genetic trick: Telomere extension drives unchecked tumor growth
PITTSBURGH — Scientists at the University of Pittsburgh School of Medicine have identified a crucial missing piece in the long-standing mystery of…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Legal Battles Over Cancer Funding Delay Life-Saving Care for Patients
-
Stanford Digital Twins Identify Drug Combo To Stop Premature Birth
-
Why Microsatellite Instability Status Dictates Rectal Cancer Treatment Choices
-
Why KRAS Was Considered Undruggable for Decades and What Finally Cracked It
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
How Private Credit Facilities Expand Access to Affordable Consumer Lending
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds